Riskpilot← Back to searchSign inGet full accessAG SUNDHEDSFREMME ApS
APSActiveCVR 30566343Klempegårdsvej 32Other human health activities n.e.c. · NACE 8699Est. 200716 employeeswww.agsundhedsfremme.dk
Revenue 2025
DKK 5,3M
+25% vs 2024
EBITDA margin
33.8%
+15% vs 2024
Equity ratio
63.6%
Financial strength
Net profit 2025
DKK 1,3M
+12% vs 2024
| Revenue | DKK 5,3M | +25% |
| EBITDA | DKK 1,8M | +15% |
| Net profit | DKK 1,3M | +12% |
| Total assets | DKK 4,3M | +17% |
| Equity | DKK 2,7M | +12% |
| Employees | 16 | — |
Legal name
AG SUNDHEDSFREMME ApS
CVR number
30566343
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
16. april 2007
Share capital
DKK 125.000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at tilbyde virksomheder sundhedsfremmende og/eller lovpligtige undersøgelser af medarbejdere, og andre tiltag til fremme af medarbejderes sundhed og trivsel.
Address
Klempegårdsvej 32
Phone
+4520229062
Email
ATr@agsundhed.dk
Website
www.agsundhedsfremme.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.743 | 1.566 | 2.474 | 4.215 | 5.254 |
| Staff expenses | -628 | -1.335 | -2.258 | -2.677 | -3.477 |
| EBITDA | 1.014 | 96 | 216 | 1.539 | 1.777 |
| Depreciation & amort. | -50 | -46 | -46 | -46 | -108 |
| EBIT | 965 | 50 | 170 | 1.493 | 1.669 |
| Net financials | -6 | -8 | 4 | 0 | -2 |
| Profit before tax | 959 | 43 | 175 | 1.493 | 1.666 |
| Tax | 212 | 10 | 39 | 331 | 368 |
| Net profit | 747 | 33 | 136 | 1.162 | 1.298 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.454 | 1.751 | 2.064 | 3.659 | 4.293 |
| Equity | 1.699 | 1.433 | 1.469 | 2.430 | 2.728 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 754 | 313 | 586 | 1.219 | 1.564 |
| Total debt | 754 | 313 | 586 | 1.219 | 1.564 |
EBITDA margin
33.8%
This company
15.8%
Market median
+114% vs market
20212025
Equity ratio
63.6%
This company
38.2%
Market median
+66% vs market
20212025
Return on equity
47.6%
This company
18.4%
Market median
+159% vs market
20212025
Net profit margin
24.7%
This company
8.1%
Market median
+205% vs market
20212025
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20212025
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AT Management | Management | 2007 |
| Former (1) | ||
PT Management | Management | 2007 – 2013 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AG Sundhedsfremme Holding Aps
AG SUNDHEDSFREMME ApS Board members of AG SUNDHEDSFREMME ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annette Trampedach | Management | 0 companies |
| Peter Trampedach | Management | 0 companies |